X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (139) 139
male (118) 118
female (115) 115
middle aged (102) 102
aged (90) 90
cardiac & cardiovascular systems (66) 66
index medicus (65) 65
risk factors (48) 48
drug therapy (43) 43
medicine, general & internal (43) 43
stroke (43) 43
double-blind method (40) 40
adult (39) 39
mortality (39) 39
treatment outcome (39) 39
risk (36) 36
abridged index medicus (35) 35
cardiovascular disease (34) 34
myocardial infarction (34) 34
prevention (34) 34
atrial fibrillation (30) 30
medicin och hälsovetenskap (29) 29
medical and health sciences (28) 28
cardiovascular diseases (27) 27
drug therapy, combination (26) 26
aspirin (24) 24
care and treatment (24) 24
follow-up studies (24) 24
heart attacks (23) 23
hemorrhage - chemically induced (23) 23
platelet aggregation inhibitors - therapeutic use (23) 23
therapy (23) 23
cardiovascular diseases - prevention & control (21) 21
electrocardiography (20) 20
atrial fibrillation - drug therapy (19) 19
incidence (19) 19
warfarin (19) 19
diabetes (18) 18
hypertension (18) 18
myocardial-infarction (18) 18
peripheral vascular disease (18) 18
acute coronary syndromes (17) 17
anticoagulants (17) 17
clinical trials (17) 17
ticlopidine - analogs & derivatives (17) 17
anticoagulants - therapeutic use (16) 16
cardiovascular diseases - mortality (16) 16
clopidogrel (16) 16
management (16) 16
myocardial infarction - drug therapy (16) 16
platelet aggregation inhibitors - adverse effects (16) 16
stroke - prevention & control (16) 16
ticlopidine - therapeutic use (16) 16
myocardial infarction - mortality (15) 15
patient outcomes (15) 15
research (15) 15
time factors (15) 15
blood pressure (14) 14
cerebral infarction (14) 14
diabetes mellitus (14) 14
health risk assessment (14) 14
heart diseases (14) 14
hemorrhage (14) 14
prospective studies (14) 14
unstable angina (14) 14
acute myocardial-infarction (13) 13
dosage and administration (13) 13
events (13) 13
health aspects (13) 13
patients (13) 13
fibrinolytic agents - therapeutic use (12) 12
medicine (12) 12
metaanalysis (12) 12
outcomes (12) 12
usage (12) 12
acute coronary syndrome - drug therapy (11) 11
aged, 80 and over (11) 11
anticoagulation (11) 11
aspirin - therapeutic use (11) 11
coronary heart disease (11) 11
kaplan-meier estimate (11) 11
myocardial infarction - complications (11) 11
proportional hazards models (11) 11
registries (11) 11
thromboembolism (11) 11
anticoagulants - adverse effects (10) 10
cardiovascular diseases - epidemiology (10) 10
cholesterol (10) 10
clinical medicine (10) 10
complications and side effects (10) 10
coronary angiography (10) 10
coronary artery bypass (10) 10
coronary artery disease (10) 10
death (10) 10
medical research (10) 10
myocardial infarction - epidemiology (10) 10
prevalence (10) 10
ticlopidine - adverse effects (10) 10
acute disease (9) 9
antithrombotic therapy (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2021 - 2031
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2009 - 2020
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2032 - 2043
In a 2-by-2 factorial trial, 12,705 persons at intermediate risk were assigned to candesartan plus hydrochlorothiazide or placebo and to rosuvastatin or... 
STROKE | MORTALITY | TRIALS | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | COUNTRIES | THERAPY | MYOCARDIAL-INFARCTION | STRATEGY | PREVENTION | INTERHEART | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Rosuvastatin Calcium - adverse effects | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Hydrochlorothiazide - administration & dosage | Rosuvastatin Calcium - administration & dosage | Antihypertensive Agents - adverse effects | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Care and treatment | Usage | Clinical trials | Rosuvastatin | Dosage and administration | Cardiovascular diseases | Risk factors | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Cardiovascular disease | Lipids | Hydrochlorothiazide | Low density lipoprotein | Cholesterol | Disease prevention | Blood pressure | Health risk assessment | Drug therapy | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article